Biophytis (BPTSY)
OTHER OTC:BPTSY
Holding BPTSY?
Track your performance easily

Biophytis (BPTSY) Stock News & Sentiment

32 Followers
Biophytis Advances Clinical Trials and Targets $100B Market
Premium
Company Announcements
Biophytis Advances Clinical Trials and Targets $100B Market
2d ago
Biophytis (BPTSY) has released an update. Biophytis SA, a Paris-based biotech company, has reported significant progress in their drug development programs, particularly with their lead candidate BIO101 for treating obesity, ...Read more
Biophytis Advances DMD Treatment with BIO101 Scale-Up
Premium
Company Announcements
Biophytis Advances DMD Treatment with BIO101 Scale-Up
4M ago
Biophytis Targets Obesity with Phase 2 Study Filing
Premium
Company Announcements
Biophytis Targets Obesity with Phase 2 Study Filing
4M ago

News Score - Last 7 Days

Neutral
BPTSY
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BPTSY’s Media Buzz Sentiment?
1 articles about BPTSY were published this week. In an average week, 1 articles are published.
    What is BPTSY’s weekly average amount of articles?
    In an average week, 1 articles about BPTSY are published.
      What is BPTSY’s News Sentiment?
      50% of articles about BPTSY were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        PRMEPrime Medicine, Inc.
        ESTAEstablishment Labs Holdings
        FYBFormycon AG
        AMEDAmedisys
        FONRFonar
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis